Prenetics Global Limited, through its premium health brand IM8, announced a partnership with the global nonprofit Vitamin Angels that will deploy evidence‑based prenatal vitamins, vitamin A supplements and deworming treatments to 400,000 pregnant women, infants and children under five in underserved communities during the first year of the program.
The collaboration leverages IM8’s clinical‑grade nutrition platform and Vitamin Angels’ established distribution network in more than 65 countries. Vitamin Angels, which serves over 74 million women and children annually, will use its proven logistics to deliver the supplements to the target population, while Prenetics will provide funding and expertise to support the initiative.
This partnership extends IM8’s mission beyond premium consumer nutrition into universal health impact, positioning the brand as a socially responsible leader. It also opens potential new revenue streams and strengthens brand equity, aligning with Prenetics’ broader strategy of scaling its health platform worldwide and focusing on IM8 as its primary growth engine.
Prenetics’ recent financial performance underscores the company’s capacity to support such initiatives. In Q4 2025 the company reported an EPS of –$0.27 and revenue of $36.60 million, both exceeding analyst expectations, and full‑year 2025 revenue surged 480% year‑over‑year to $92.4 million, driven largely by IM8’s rapid growth.
The partnership signals Prenetics’ commitment to leveraging its commercial success for broader social impact while reinforcing its strategic focus on IM8. By combining IM8’s product expertise with Vitamin Angels’ delivery infrastructure, the company can expand its reach, enhance its brand reputation, and potentially generate new revenue streams that complement its existing business model.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.